Abstract:AIM:To investigate the relationship between hypoxia-inducible factor-1α (HIF-1α), prolyl 4-hydroxylase beta (P4HB) expression, and clinicopathologic parameters, as well as the prognostic value of these genes for patients with gastric cancer (GC). METHODS:Hypoxia is a critical factor that shapes the GC microenvironment. In previous reports, we have demonstrated that P4HB is a potential target of HIF-1α. In the present study, gene expression profiling interactive analysis (GEPIA) was used to analyze the relationship between P4HB and hypoxia-associated genes. To this end, 428 GC tissue samples were used to analyze the expression of HIF-1α and P4HB via immunohistochemical staining. Patient samples were classified as having weak-expression or over-expression both in terms of HIF-1α and P4HB. Correlations between biomarkers and clinicopathological factors were analyzed to predict survival. RESULTS:P4HB demonstrated a positive correlation with hypoxia-associated genes (P < 0.05). HIF-1α and P4HB overexpression have a significant correlation with TNM staging (χ2 = 23.32, P = 0.00; χ2 = 65.64, P = 0.00) and peritoneum cavity metastasis (χ2 = 12.67, P = 0.00; χ2 = 39.29, P = 0.00). In univariate analysis, patients with a high HIF-1α expression trend had a shorter disease-free survival (DFS: 44.80 mo vs 22.06 mo) and overall survival (OS: 49.58 mo vs 39.92 mo). P4HB overexpression reflected similar results: patients with over-expression of P4HB had a shorter survival time than those with weak-expression (DFS: 48.03 mo vs 29.64 mo, OS: 52.48 mo vs 36.87 mo). Furthermore, HIF-1α is also a clinicopathological predictor of dismal prognosis according to multivariate analysis (DFS, 95%CI: 0.52-0.88, P < 0.00; OS, 95%CI: 0.50-0.85, P < 0.00). However, P4HB was meaningful in DFS (95%CI: 0.58-1.00, P < 0.05) but not in OS (95%CI: 0.72-1.23, P > 0.05). CONCLUSION:Overexpression of HIF-1α and P4HB is associated with poor prognosis in patients with GC. Thus, these genes may be potential prognostic biomarker candidates in GC.

Expression of Monocyte Chemotactic Protein-1/Ccl2 in Gastric Cancer and Its Relationship with Tumor Hypoxia

Increased Expression of C-C Motif Ligand 2 Associates with Poor Prognosis in Patients with Gastric Cancer after Gastrectomy

Meta-analysis of Immunohistochemical Expression of Hypoxia Inducible Factor-1Α As a Prognostic Role in Gastric Cancer.

Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis

Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer

High Expression of C-C Chemokine Receptor 2 Associates with Poor Overall Survival in Gastric Cancer Patients after Surgical Resection

C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer.

Expression and prognostic role of CXCL5 in gastric cancer

CXCL1 Gene Silencing Inhibits HGC803 Cell Migration and Invasion and Acts As an Independent Prognostic Factor for Poor Survival in Gastric Cancer

CXCL1 Promotes Tumor Growth Through VEGF Pathway Activation and is Associated with Inferior Survival in Gastric Cancer.

Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma.

Chemokine (C-X-C Motif) Ligand 1 is Associated with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer

The Prognostic Value of CXC-chemokine Receptor 2 (CXCR2) in Gastric Cancer Patients

Prognostic and Clinicopathological Significance of CXCL1 Expression in Gastric Cancer: A Meta-Analysis.

HIF1α/CCL7/KIAA1199 Axis Mediates Hypoxia-Induced Gastric Cancer Aggravation and Glycolysis Alteration

Expression of C-X-C Chemokine Receptor Types 1/2 in Patients with Gastric Carcinoma: Clinicopathological Correlations and Significance.

Hypoxia-inducible Factor-1 Alpha Correlates with Tumor-Associated Macrophages Infiltration, Influences Survival of Gastric Cancer Patients.

Prognostic Value of Hypoxia-Inducible Factor-1 Alpha and Prolyl 4-Hydroxylase Beta Polypeptide Overexpression in Gastric Cancer

Expression of Monocyte Chemoattractant Protein-1 and CC Chemokine Receptor 2 in Non-Small Cell Lung Cancer and Its Significance

CXC Chemokine Receptor 1 Predicts Postoperative Prognosis and Chemotherapeutic Benefits for TNM II and III Resectable Gastric Cancer Patients.

Lysyl Oxidase and Hypoxia-Inducible Factor 1α: Biomarkers of Gastric Cancer